glp-1 risk dvt A recent study suggests that medications, commonly prescribed for managing diabetes and obesity, may also lower the of dangerous blood clots., The study’s lead author, Dr. Rushad Patell of 💡 Have you or someone

SGLT2 inhibitors, but not GLP-1 receptor agonists, reduce incidence of gout in people living with type 2 diabetes across the therapeutic spectrum

Additional Peptides : Research continues into other peptides that might offer similar effects as BPC 157

Bulama I, Saidu UF, Suleiman N, Abbas A, Saidu Y, Yakubu Y, et al

Neuroprotection: BPC-157 has been shown to provide some neuroprotective effects in rats, helping to protect against harmful free radical damage or protect the brain and preserve brain function after exposure to harmful substances [3]

Produce collagen, the connective tissue that supports our organs and forms the bones, skin, ligaments, tendons, and joints